AMLX - Amylyx Pharmaceuticals O‘sish sur’atiga tuzatilgan narx-foyda
Baxolash va o'sish muvozanati ko'rsatkichi avtomatlashtirilgan molekulyar skrining tizimlarini joriy etishning Amylyx Pharmaceuticals (AMLX) narxlar dinamikasiga ta'sirini namoyish etadi. Shu bilan birga, 0.00 yangi daraja belgisini qayd etmoqda. Jori tendentsiya asosiy dori vositasining muvaffaqiyatsizligidan keyingi qat'iy rahbarlik transformatsiyasi hamda tibbiyot hamjamiyatining kompaniyaning ALS ni davolash missiyasiga bo'lgan yuqori ishonchi bilan boshqarilmoqda.
Amylyx Pharmaceuticals (AMLX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi statistikasi:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Amylyx Pharmaceuticals|AMLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati amylyx.com|AMLX - Kompaniya qarzlari|Qarzlarning balans kapitallashuviga nisbati Amylyx|AMLX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Amylyx Pharmaceuticals|Tezkor likvidlik koeffitsiyenti amylyx.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
AMLX - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Amylyx Pharmaceuticals|AMLX - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Amylyx Corp|AMLX - PEG multiplikatori|EV/EBITDA multiplikatori Amylyx|AMLX - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Amylyx Pharmaceuticals|AMLX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi amylyx.com|AMLX - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Amylyx Pharmaceuticals
Kompaniyaning fundamental tahlili:Amylyx Pharmaceuticals Inc - AMLX
Amylyx Pharmaceuticals (AMLX) davosiz neyrodegenerativ kasalliklar terapiyasida mutlaq narx belgilash kuchiga ega bo'lib, bu bozor tebranishlariga qarshi yuqori foyda barqarorligini ta'minlaydi. Foyda o'sish sur'atlariga nisbatan ushbu og'irlikka ega P/E ko'rsatkichi aktivning bozor qiymatini uning kengayish dinamikasi bilan solishtiradi va fundamental past baholanganlikni kredit risklaridan ajratish imkonini beradi. Grafikdagi birdan pastki qiymatlar xavfsizlikning sezilarli zaxirasi va kapitalizatsiyaning tez o'sishi potentsialidan dalolat beradi.
Raqobatdosh kompaniyalar
Narx-foyda va o‘sish multiplikatori Biogen Inc BIIB|Neurocrine Biosciences Inc - Narx-foyda va o‘sish multiplikatori|Regencell Corp (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|ACAD: Narxning foydaga va o‘sish sur’atiga nisbati|XENE (Xenon) - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Viking Therapeutics Inc (VKTX)|Narx-foyda va o‘sish multiplikatori SUPN|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CPRX (Catalyst Corp)|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics)|HRMY (harmonybiosciences.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|TRVI (Trevi Therapeutics Inc) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Praxis Medicines - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AVXL (Anavex Life Sciences Corp)|CBLL: PEG multiplikatori|Prothena (PRTA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Alector Inc.|ANNX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Omeros Corporation (OMER)|Narx-foyda va o‘sish multiplikatori Neurogene Therapeutics NGNE|PEG multiplikatori ACIU (AC Immune)|PEG multiplikatori voyagertherapeutics.com VYGR|Neumora Therapeutics, Inc. - PEG multiplikatori|Scilex Holding (SCLX) - Narx-foyda va o‘sish multiplikatori|TVGN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Alpha Cognition Inc. (ACOG)|Narx-foyda va o‘sish multiplikatori CGTX|PEG multiplikatori inhibikase.com|Narx-foyda va o‘sish multiplikatori SAVA (Cassava Sciences)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati ASRT|PEG multiplikatori COYA (Coya Therapeutics)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati VistaGen Therapeutics, Inc. (VTGN)|Ovid Rx - PEG multiplikatori|acumenpharm.com (ABOS) - Narx-foyda va o‘sish multiplikatori|CRVO: PEG multiplikatori|Alterity Therapeutics Limited (ATHE) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc|Narxning foydaga va o‘sish sur’atiga nisbati PEPG|Narxning foydaga va o‘sish sur’atiga nisbati Jupiter Neurosciences Inc (JUNS)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati relmada.com|PEG multiplikatori ANVS (Annovis Bio)|PEG multiplikatori Grace Therapeutics Inc GRCE|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|Klotho Neurosciences Inc (KLTO) - Narx-foyda va o‘sish multiplikatori|neurosense-tx.com (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|RVPH (revivapharma.com) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori MTVA|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NRXS (NeurAxis Inc.)|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|passagebio.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori NEUP (Neuphoria Therapeutics)|minervaneurosciences.com (NERV) - O‘sish sur’atiga tuzatilgan narx-foyda|ATHA: Narx-foyda va o‘sish multiplikatori|ADXN - PEG multiplikatori|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion Therapeutics, Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|O‘sish sur’atiga tuzatilgan narx-foyda Pasithea KTTA|PEG multiplikatori CRGT|PEG multiplikatori Avenue Therapeutics Inc. (ATXI)|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|CARA - Narx-foyda va o‘sish multiplikatori|CHRO: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Eliem Therapeutics|intracellulartherapies.com (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|LBPH (Longboard Pharmaceuticals Inc) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori MRNS|O‘sish sur’atiga tuzatilgan narx-foyda NKGen Biotech Corp NKGN|Narx-foyda va o‘sish multiplikatori NRBO (NeuroBo Pharmaceuticals)|sagerx.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Synaptogenix - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TRVN|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati WENA|CERE: PEG multiplikatori
